Taysha Gene Therapies Inc (TSHA)
Healthcare
Biotechnology
—
5.80 $
-1.4%
vs. previous close
Closing price · As of: 3. Aug 2026
Taysha Gene Therapies Inc (TSHA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -41 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -19 | -18 | -16 | -20 | -22 | -22 | -18 | -22 | -20 | -24 | -27 | -41 | -112 | |
| 0.3 | 0.3 | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 1.2 | |
| 2.2 | 2.0 | 2.0 | 3.2 | 3.3 | 3.4 | 3.2 | 3.3 | 3.2 | 3.3 | 3.5 | 5.5 | 16 | |
| 6.0 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.8 | -7.4 | -4.8 | 0.3 | -4.3 | -5.9 | -2.6 | -4.6 | 2.2 | 4.0 | -7.1 | -4.7 | -5.5 | |
| 0.0 | 3.5 | 0.0 | 0.1 | 0.2 | 0.0 | 0.0 | 0.4 | 0.0 | 0.1 | 0.3 | 3.0 | 3.4 | |
| 0.0 | -3.5 | 0.0 | -0.1 | -0.2 | 0.0 | 0.0 | -0.4 | 0.1 | 0.0 | -0.2 | -3.0 | -3.3 | |
| 0.5 | – | -0.4 | – | – | – | – | – | – | -0.2 | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | 0.0 | – | – | |
| 0.4 | 141 | -4.2 | 0.0 | 70 | 6.6 | -0.4 | -0.1 | 216 | 8.8 | 50 | 0.7 | 275 | |
| -18 | 119 | -20 | -20 | 49 | -15 | -19 | -22 | 196 | -15 | 23 | -43 | 160 | |
| -19 | -21 | -16 | -20 | -22 | -22 | -18 | -22 | -20 | -24 | -27 | -44 | -115 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.